With the continuous growth of China's economy, the continuous improvement of people's living standards, the gradual improvement of the medical security system, and the increasingly prominent problem of aging population, China's pharmaceutical industry has shown a sustained good trend of development, maintaining a long-term output growth of more than 10%, becoming one of the fastest growing markets in the world. In this context, how to objectively evaluate the business performance of enterprises is a major problem facing pharmaceutical enterprises at present, and it is also the focus of investors and other stakeholders. This paper tries to introduce economic value added (EVA) index into the pharmaceutical industry, designs and adjusts the calculation formula of EVA, and takes HengRui Medicine as an example to make a specific analysis of its business performance, so as to provide reference for the performance evaluation of the pharmaceutical industry in China.

Mengxue Wu. Performance Evaluation of Listed Pharmaceutical Companies Based on EVA. Academic Journal of Engineering and Technology Science (2020) Vol. 3 Issue 8: 25-35. https://doi.org/10.25236/AJETS.2020.030803.

[1] Yu Suyue, Sui Min. Research on performance evaluation and incentives based on the implementation of accounting standards [J]. Shandong Social Sciences, 2019 (04): 143-147.
[2] Kang Ling. The design of corporate performance evaluation system based on EVA and BSC——Taking Poly Real Estate (Group) Co., Ltd. as an example [J]. Finance and Accounting Newsletter, 2016 (20): 51-54.
[3] Zhao Shuhui. Research on the Application of EVA in the Performance Evaluation of Bank of China [J]. Friends of Accounting, 2016 (07): 34-37.
[4] Yang Zhenqing, Li Xiaofen. Summary of Research on EVA Performance Evaluation of Listed Companies [J]. Finance and Accounting Newsletter, 2015 (16): 54-56.
[5] Zhang Haixia. Performance evaluation of listed real estate companies based on EVA——Taking Poly Real Estate as an example [J]. Finance and Accounting Monthly, 2015 (09): 56-59.
[6] Ju Fang, Li Liping, Wang Zhenrui. The application of EVA in the performance evaluation of electric power companies: Taking Inner Mongolia Huadian as an example [J]. Finance and Accounting Newsletter, 2014 (08): 55-57
[7] Qin Zhimin, Zhao Liyun, Liang Hongru. EVA analysis of the value creation ability of listed companies in my country's air transportation industry [J]. Finance and Accounting, 2014 (02): 28-31.
[8] Wu Yunqi. Research on the application status of EVA in listed companies [J]. Finance and Accounting Newsletter, 2012 (26): 24-26.
[9] Tian Jie. The application of EVA performance evaluation method in listed coal companies——Taking Shanxi coal listed companies as an example [J]. Friends of Accounting, 2012 (02): 36-38.
[10] Gao Yan. EVA calculation adjustments based on the framework of accounting standards [J]. Finance and Accounting Monthly, 2011 (32): 53-54.
[11] Tao Xionghua, Lu Li. Analysis of EVA value creation and influencing factors of my country's commercial banks [J]. Journal of Zhongnan University of Economics and Law, 2010 (05): 89-94.